Testing program for people at risk of hepatitis C
Part of Digestive system, Infections clinical trials.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You can and are willing to give informed consent
- You have at least one hepatitis C risk factor, such as past or current injecting drug use
- OR you attend a service that supports people at hepatitis C risk (like needle/syringe programs or prisons)
- You can follow the study steps and requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is setting up a program to test adults for hepatitis C antibodies using quick, point-of-care tests. It helps confirm how well this testing approach works in real-world care so more people can be identified and treated earlier.
This study collects basic information from adults who already had a quick, on-site hepatitis C (HCV) test. It aims to improve how point-of-care testing is done and documented, which may lead to faster follow-up and care.
This study looks at how emergency department patients feel about a new, quick test for hepatitis C. If you have tested positive for hepatitis C antibodies but haven't had a follow-up test to confirm an active infection, you might be able to join and share your thoughts on this new testing approach.
This trial tests how acceptable it is for people who use services outside traditional clinics to be screened for hepatitis B, hepatitis C, and HIV during the same visit. If you join, you would be asked to participate and provide consent for the screening process.
This study tests a home test for hepatitis C that you can use yourself. It checks if adults can use the test correctly by following the instructions.
This study aims to make hepatitis C treatment simpler and more accessible for people who inject drugs. If you join, you'll receive care that fits your lifestyle and helps cure hep C.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.